<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"><!-- InstanceBegin template="/Templates/template.dwt" codeOutsideHTMLIsLocked="false" -->
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<title>ProteoTech Inc. &mdash; News/Publications: News/Press Releases</title>
		<meta name="Description" content="ProteoTech news and press releases" />
		<meta name="Keywords" content="Exebryl-1, Alzheimer's disease, The Michael J. Fox Foundation for Parkinson's Research, Parkinson's disease, Parkinson's progression, SBIR award, National Institute of Aging, NIA, proteoglycan, Systemic AA Amyloidosis, proteoglycan transgenic mice" />
		<meta name="Language" content="English" />
		<meta name="Robots" content="All" />
		<link href="/css/styles.css" rel="stylesheet" type="text/css" media="screen" />
		<link href="/css/print.css" rel="stylesheet" type="text/css" media="print" />
		<!--[if lte IE 6]>
			<link href="/css/lteie6.css" rel="stylesheet" type="text/css" media="screen" />
		<![endif]-->
		<!--[if IE 6]>
			<link href="/css/ie6.css" rel="stylesheet" type="text/css" media="screen" />
		<![endif]-->
		<!--[if IE 7]>
			<link href="/css/ie7.css" rel="stylesheet" type="text/css" media="screen" />
		<![endif]-->
		<script type="text/javascript" src="/js/p7popmenu-packed.js"></script>
		<script type="text/javascript" src="/js/SpryEffects-packed.js"></script>
		<script type="text/javascript" src="/js/p7vscscripts.js"></script>
		<script type="text/javascript">
			<!--
			function MM_effectAppearFade(targetElement, duration, from, to, toggle) {
				Spry.Effect.DoFade(targetElement, {duration: duration, from: from, to: to, toggle: toggle});
			}
			//-->
		</script>
	</head>
	<body onload="P7_initPM(1,0,1,-20,10)">
		<div id="wrapper">
			<div class="contactAppear" id="contactAppear">
				<p><strong><img src="images/logo.gif" width="219" height="57" align="right" class="logo" /></strong></p>
				<p>
					<strong>ProteoTech, Inc</strong>. <br />
					12040 115th Ave., NE<br />
					Kirkland, WAÂ 98034
				</p>
				<p>
					<strong>Office:</strong> (425) 823-0400<br />
					<strong>Fax: </strong>(425) 823-8508<br />
					<strong>E-mail: </strong> <a href="mailto:info@proteotech.com">info@proteotech.com</a>
				</p>
				<p align="right" class="close"><a href="#" onclick="MM_effectAppearFade('contactAppear', 800, 100, 0, false)">Close Window</a></p>
			</div>
			<div id="logoBand">
				<h1 class="logoBox">
					<a href="../index.html" title="ProteoTech, World Leader in Therapeutics and Diagnostics Targeting Amyloid Diseases">
						<img src="../images/logo.gif" alt="" width="219" height="57" border="0" alt="ProteoTech, Inc" />
					</a>
				</h1>
				<div class="taglineBox">
					<h2>A World Leader in Therapeutics Targeting Misfolded Proteins and Amyloid Diseases</h2>
				</div>
			</div>
			<div id="photoBand">
				<div class="mainPhotoBox"><img src="../images/home_photo_temp.gif" width="680" height="205" /></div>
				<div class="sidebarPhotoBox"><img src="../images/news.jpg" width="214" height="205" /></div>
			</div>
			<div id="contentBox">
				<div id="navBox">
					<ul id="p7PMnav">
						<li><a href="/" title="ProteoTech Home">Home</a></li>
						<li><a href="/about/mission.html" title="About ProteoTech, Inc" class="p7PMtrg">About Us</a>
							<ul>
								<li><a href="/about/mission.html" title="Our Mission">Our Mission</a></li>
								<li><a href="/about/history.html" title="Our History">Our History</a></li>
								<li><a href="/about/targets.html" title="Targeted Markets">Targeted Markets</a></li>
								<li><a href="/about/intellectual.html" title="Intellectual Property">Intellectual Property</a></li>
								<li><a href="/about/leadership_team.html" title="ProteoTech's Leadership Team">Leadership Team</a></li>
							</ul>
						</li>
						<li><a href="/technologies/proteoglycan.html" title="ProteoTech's Technologies" class="p7PMtrg">Our Technologies</a>
							<ul>
								<li><a href="/technologies/proteoglycan.html" title="Amyloid &amp; Proteoglycan Technologies">Amyloid &amp; Proteoglycan Technologies</a></li>
								<li><a href="/technologies/therapeutic_approach.html" title="Therapeutic Approach">Therapeutic Approach</a></li>
								<li><a href="/technologies/alzheimers_small.html" title="Alzheimer's Small Molecule">Alzheimer's - Small Molecule</a></li>
								<li><a href="/technologies/alzheimers_peptide.html" title="Alzheimer's Peptide">Alzheimer's - Peptide</a></li>
								<li><a href="/technologies/parkinsons.html" title="Parkinson's Small Molecule">Parkinson's - Small Molecule</a></li>
								<li><a href="/technologies/systemic.html" title="AL Amyloidosis - Small Molecule">AL Amyloidosis - Small Molecule</a></li>
							</ul>
						</li>
						<li><a href="/pipeline/pipeline_overview.html" title="Pipeline" class="p7PMtrg">Pipeline</a>
							<ul>
								<li><a href="/pipeline/pipeline_overview.html" title="Pipeline Overview">Overview</a></li>
								<li><a href="/pipeline/exebryl.html" title="Exebryl-1">Exebryl-1<sup>&reg;</sup></a></li>
								<li><a href="/pipeline/pepticlere.html" title="PeptiClere">PeptiClere<sup>&trade;</sup></a></li>
								<li><a href="/pipeline/synuclere.html" title="Synuclere">Synuclere<sup>&trade;</sup></a></li>
								<li><a href="/pipeline/systebryl.html" title="Systebryl">Systebryl<sup>&trade;</sup></a></li>
							</ul>
						</li>
						<li><a href="/news/news_press.html" title="ProteoTech News and Publications" class="p7PMtrg">News/Publications</a>
							<ul>
								<li><a href="/news/news_press.html" title="News/Press Releases">News / Press Releases</a></li>
								<li><a href="/news/scientific_pubs.html" title="Scientific Publications">Scientific Publications</a></li>
							</ul>
						</li>
						<li><a href="/contact.shtml" title="Contact ProteoTech">Contact Us</a></li>
					</ul>
				</div>
				<table width="895" border="0" cellspacing="0" cellpadding="0">
				<tr class="curvy"><td><img src="../images/curves_top.gif" alt="Proteotech" width="895" height="16"/></td></tr>
					<tr>
						<td class="BG_content_fill">
							<div id="column1">
								<p><img src="../images/title_news.gif" width="275" height="36" /></p>
								<p class="date"><strong>July 18, 2012</strong></p>
								<p><a href="/pdfs/20120718-Dr Judy Cam Presents at the Alzheimers Association in Vancouver BC.pdf" target="_blank" title="ProteoTech to present at The Alzheimer's Association International Conference 2012 (AAIC)&reg; in Vancouver, British Columbia, Canada.">ProteoTech to present at The Alzheimer's Association International Conference 2012 (AAIC)&reg; in Vancouver, British Columbia, Canada.</a></p>
								<p class="date"><strong>April 23, 2012</strong></p>
								<p><a href="/pdfs/20120423-Dr Alan Snow Presenting at Symposium on Amyloidosis.pdf" target="_blank" title="ProteoTech's Chief Scientific Officer, Dr. Alan Snow, to Present New Data on at the XIIIth International Symposium on Amyloidosis">ProteoTech's Chief Scientific Officer, Dr. Alan Snow, to Present New Data on at the XIIIth International Symposium on Amyloidosis</a></p>
								<p class="date"><strong>December 20, 2011</strong></p>
								<p><a href="/pdfs/20111220-Collaborative Agreement with Glaxo Smith Kline.pdf" target="_blank" title="ProteoTech Announces Drug Development Collaborative Agreement with GlaxoSmithKline for New Parkinson's Therapeutic">ProteoTech Announces Drug Development Collaborative Agreement with GlaxoSmithKline for New Parkinson's Therapeutic</a></p>
								<p class="date"><strong>September 22, 2011</strong></p>
								<p><a href="/pdfs/20110922-Neurodegenerative Conditions Conference.pdf" target="_blank" title="ProteoTech to Present at The 5th Annual Neurodegenerative Conditions Research and Development Conference in San Francisco, California">ProteoTech to Present at The 5th Annual Neurodegenerative Conditions Research and Development Conference in San Francisco, California</a></p>
								<p class="date"><strong>July 16-21, 2011</strong></p>
								<p><a href="/pdfs/20110716-ProteoTech to Present at Alzheimers Conference.pdf" target="_blank" title="ProteoTech to Present at Alzheimer's Association International Conference (AAIC) 2011, in Paris, France">ProteoTech to Present at Alzheimer's Association International Conference (AAIC) 2011, in Paris, France</a></p>
								<p class="date"><strong>June 15, 2011</strong></p>
								<p><a href="/pdfs/20110615-ProteoTech Awarded US Government Grant.pdf" target="_blank" title="ProteoTech Awarded $770,675 U.S. Government Grant from the National Institute of Health">ProteoTech Awarded $770,675 U.S. Government Grant from the National Institute of Health for "Identification of Novel Small Molecules as Tau Protein Aggregation Inhibitors" for Potential Therapeutics for Alzheimer's Disease</a></p>
								<p class="date"><strong>March, 2011</strong></p>
								<p><a href="/pdfs/201103-Esposito Barcelona.pdf" target="_blank" title="ProteoTech to Present at The 10th International Conference on Alzheimer's and Parkinson's Disease in Barcelona, Spain">ProteoTech to Present at The 10th International Conference on Alzheimer's and Parkinson's Disease in Barcelona, Spain</a></p>
								<p class="date"><strong>February, 2011</strong></p>
								<p><a href="/pdfs/201102-Snow San Diego.pdf" target="_blank" title="Proteotech's CSO Dr. Alan Snow to speak at the 5th Drug Discovery for Neurodegeneration Conference">Proteotech's CSO Dr. Alan Snow to speak at the 5th Drug Discovery for Neurodegeneration Conference</a></p>
								<p class="date"><strong>December, 2010</strong></p>
								<p><a href="/pdfs/201012-Runnels Xconomy.pdf" target="_blank" title="Proteotech's CEO Steve Runnels Featured in Recent Xconomy/Seattle Aritcle">Proteotech's CEO Steve Runnels Featured in Recent Xconomy/Seattle Aritcle</a></p>
								<p class="date"><strong>November, 2010</strong></p>
								<p><a href="/pdfs/201011-QTDP Grant.pdf" target="_blank" title="ProteoTech Awarded U.S. Government Grants for Five Qualifying Therapeutic Development Projects">ProteoTech Awarded U.S. Government Grants for Five Qualifying Therapeutic Development Projects</a></p>
								<p class="date"><strong>October 26, 2010</strong></p>
								<p><a href="/pdfs/10262010-ProteoTech Presents at the 8th Annual International Drug Discovery Sciences and Technology.pdf" target="_blank">ProteoTech's CEO, Steve Runnels Presents at the 8th Annual Congress of International Drug Discovery Sciences and Technology</a></p>
								<p class="date"><strong>October 26, 2010</strong></p>
								<p><a href="/pdfs/10262010-ProteoTech Dr Snow presents at Bejing Congress.pdf" target="_blank">ProteoTech's CSO, Dr. Snow presents at the 8th Annual Congress of International Drug Discovery Sciences and Technology</a></p>
								<p class="date"><strong>September 30, 2009</strong></p>
								<p><a href="/pdfs/09302009-Luke present MJFF Symposium.pdf" target="_blank">ProteoTech to participate in Michael J. Fox Foundation Parkinson's Disease Therapeutics Conference â New York, NY, September 30, 2009</a></p>
								<p class="date"><strong>July 09, 2009</strong></p>
								<p><a href="/pdfs/07112009-Qubai Present Alzheimer Conference.pdf" target="_blank">ProteoTech presents at Alzheimer's Association International Conference on Alzheimer's Disease â Vienna, Austria, July 11-16, 2009</a></p>
								<p class="date"><strong>June 07, 2009</strong></p>
								<p><a href="/pdfs/06072009-Proteotechs Esposito to Present at The Movement Disorder Society 2.pdf" target="_blank">ProteoTech presents at 13th International Congress of Parkinson's Disease and Movement Disorders â Paris, France, June 7-11, 2009</a></p>
								<p class="date"><strong>March 09, 2009</strong></p>
								<p><a href="/pdfs/2009_03_09-Intl ADPD Meeting Press Release.pdf" target="_blank">ProteoTech to Present at 9th International Conference for Alzheimer's and Parkinson's Disease â Prague, Czech Republic, March 11-15, 2009</a></p>
								<p class="date"><strong>February 26, 2009</strong></p>
								<p><a href="/pdfs/20090229_MJF_imaging_award_press_release.pdf" target="_blank">ProteoTech Receives Funding from The Michael J. Fox Foundation for Parkinson's Disease Research to Develop Tools for Imaging Alpha-Synuclein Aggregation in Living Parkinson's Brain</a></p>
								<p class="date"><strong>December, 2008</strong></p>
								<p><a href="/pdfs/2009_readersDigest.pdf" target="_blank">"Advances In: Treating Alzheimer's" - ProteoTech's Alzheimer's Drug <strong><a href="/pipeline/exebryl.html" title="Exebryl-1">Exebryl-1</a><sup>&reg;</sup></strong> was featured in the Dec 2008 Issue of Reader's Digest</a></p>
								<p class="date"><strong>November 11, 2008 </strong></p>
								<p><a href="/pdfs/Nov 11_2008.pdf" target="_blank">ProteoTech to Present at Rodman &amp; Renshaw's 10th Annual Healthcare Conference</a></p>
								<p class="date"><strong>August 07, 2008 </strong></p>
								<p><a href="/pdfs/Press Releases 08-07-2008.pdf" target="_blank">ProteoTech's <strong><a href="/pipeline/exebryl.html" title="Exebryl-1">Exebryl-1</a><sup>&reg;</sup></strong> Enters Human Clinical Trials for the Treatment of Alzheimer's Disease</a> </p>
								<p class="date"><strong>February, 2006 </strong></p>
								<p><a href="/pdfs/MJFF_article.pdf" target="_blank">Michael J. Fox Foundation to Provide Up to $3.1 Million for Development of New Therapy to Stop Parkinson's Progression</a></p>
								<p class="date"><strong>August 4, 2004</strong></p>
								<p><a href="/pdfs/Aug 4_2004.pdf">ProteoTech Receives Phase I SBIR Award from the National Institute on Aging to Study the Role of Proteoglycans in Brain During Development of Alzheimer's Disease</a></p>
								<p class="date"><strong>September 24, 2004</strong></p>
								<p><a href="/pdfs/Sep 24_2004.pdf" target="_blank">ProteoTech Receives Phase I SBIR Award From the National Institute of Health to Develop Small Molecule Therapeutics for the Treatment of Systemic AA Amyloidosis</a></p>
								<p class="date"><strong>May 27, 2003</strong></p>
								<p><a href="/pdfs/May 27_2003.pdf" target="_blank">ProteoTech Receives Issuance of US Patent Pertaining to the Generation of Proteoglycan Transgenic Mice</a></p>
								<p class="date"><strong>June 5, 2003</strong></p>
								<p><a href="/pdfs/June 5_2003.pdf" target="_blank">ProteoTech Receives Phase I SBIR Award from the National Institute on Aging to Study the Role of Proteoglycans in Brain During Development of Alzheimer's Disease</a></p>
								<p class="date"><strong>October 2, 2002</strong></p>
								<p><a href="/pdfs/Oct 2_2002.pdf" target="_blank">ProteoTech Receives Issuance of US Patent Pertaining to Diagnostic Applications of Particular Proteoglycans</a></p>
								<p class="date"><strong>January 21, 1994 Wall Street Journal</strong></p>
								<p><a href="/pdfs/Jan 21_1994 WSJ.pdf" target="_blank">Study With Rats Mimics Damage From Alzheimer's</a></p>
							</div>
							<div id="column2">
								<script src="/js/pageparts/executive-summaries.js"></script>
								<script src="/js/pageparts/news.js"></script>
							</div>
						</td>
					</tr>
				<tr class="curvy"><td><img src="../images/curves_bottom.gif" alt="Proteotech" width="895" height="16" /></td></tr>
				</table>
			</div>
		</div>
		<div id="footerBox">
			<div id="footer">
				<p>Copyright &copy; 2014 ProteoTech, Inc.<br />425.823.0400&nbsp;&nbsp; <a href="mailto:info@proteotech.com">info@proteotech.com</a></p>
			</div>
		</div>
		<script type="text/javascript">
			var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
			document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
			var pageTracker = _gat._getTracker("UA-5988449-1");
			pageTracker._trackPageview();
		</script>
	</body>
</html>
